Preserving renal function and controlling oncological outcomes are pertinent when manag-ing renal neoplasms. Cryoablation is the recommended treatment only for clinical T1a stage renal tumour. Here, we compared the outcomes of robot-assisted laparoscopic partial nephrectomy (RaPN) and laparoscopic cryoablation (LCA) in the treatment of patients with localised T1-T2 renal tumours. Overall, 86 patients who received RaPN and 78 patients underwent LCA were included in this study. The intraoperative, postoperative, and oncological outcomes in the LCA group were non-inferior to the RaPN group. Moreover, LCA demonstrated shorter operative time (267.45 ± 104.53 min vs. 138.56 ± 45.28 min, p < 0.001), lower blood loss (300.56 ± 360.73 mL vs. 30.73 ± 50.31 mL, p < 0.001), and slight renal function deterioration because of the reduced invasiveness, without compromising on the oncological outcomes.
CITATION STYLE
Liu, H. Y., Kang, C. H., Wang, H. J., Chen, C. H., Luo, H. L., Chen, Y. T., … Chiang, P. H. (2021). Comparison of robot-assisted laparoscopic partial nephrectomy with laparoscopic cryoablation in the treatment of localised renal tumours: A propensity score-matched comparison of long-term outcomes. Diagnostics, 11(5). https://doi.org/10.3390/diagnostics11050759
Mendeley helps you to discover research relevant for your work.